跳至主要内容
临床试验/NL-OMON24029
NL-OMON24029尚未招募不适用

The identification and validation of risk factors to enable objective risk-stratification to predict malignant progression in Barrett’s Esophagus: a prospective multi-center study in community hospitals in the Amsterdam region

Department of Gastroenteroogy and Hepatology, Amsterdam University Medical Centres (Amsterdam UMC)0 个研究点目标入组 700 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
700

研究概览

简要总结

/A

研究设计

研究类型
Observational

入排标准

入选标准

  • Aged between 18 and 75 years
  • -Endoscopic and histological evidence of NDBE (defined as intestinal metaplasia without dysplasia) with a circumferential extent of =2 cm and a total maximum extent of =10 cm
  • -Ability to provide a written informed consent

排除标准

  • -Visible lesions in the esophagus suspicious for neoplasia during the first endoscopy (according to the Paris classification)
  • -History of HGD or EAC in the esophagus
  • -Unfit for endoscopic surveillance or inability to obtain biopsies
  • -History of endoscopic or surgical treatment for esophageal dysplasia or EAC
  • -History of esophageal surgery other than fundoplication
  • -Presence of grade C or grade D erosive esophagitis (according to Los Angeles classification)
  • -Refusal or inability to provide written informed consent

研究者

发起方
Department of Gastroenteroogy and Hepatology, Amsterdam University Medical Centres (Amsterdam UMC)

相似试验